BIOA Covered Call Strategy
BIOA (BioAge Labs Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
BIOA (BioAge Labs Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $399.1M, a beta of 0.93 versus the broader market, a 52-week range of 4.38-25.955, average daily share volume of 700K, a public-listing history dating back to 2024, approximately 61 full-time employees. These structural characteristics shape how BIOA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.93 places BIOA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on BIOA?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
BIOA snapshot
As of August 14, 2026, spot at $10.54, ATM IV 55.90%, IV rank 8.43%, expected move 16.03%. The covered call on BIOA below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on BIOA specifically: BIOA IV at 55.90% is on the cheap side of its 1-year range, which means a premium-selling BIOA covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 16.03% (roughly $1.69 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BIOA expiries trade a higher absolute premium for lower per-day decay. Position sizing on BIOA should anchor to the underlying notional of $10.54 per share and to the trader's directional view on BIOA stock.
BIOA covered call setup
The BIOA covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BIOA at $10.54 on that close, the first option leg uses a $11.07 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BIOA chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BIOA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $10.54 | long |
| Sell 1 | Call | $11.07 | N/A |
BIOA covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
BIOA covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on BIOA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on BIOA
Covered calls on BIOA are an income strategy run on existing BIOA stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
BIOA thesis for this covered call
The market-implied 1-standard-deviation range for BIOA extends from approximately $8.85 on the downside to $12.23 on the upside. A BIOA covered call collects premium on an existing long BIOA position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether BIOA will breach that level within the expiration window. Current BIOA IV rank near 8.43% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BIOA at 55.90%. As a Healthcare name, BIOA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BIOA-specific events.
BIOA covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BIOA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BIOA alongside the broader basket even when BIOA-specific fundamentals are unchanged. Short-premium structures like a covered call on BIOA carry tail risk when realized volatility exceeds the implied move; review historical BIOA earnings reactions and macro stress periods before sizing. Always rebuild the position from current BIOA chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on BIOA?
- A covered call on BIOA is the covered call strategy applied to BIOA (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With BIOA stock at $10.54 on the most recent close, the strikes shown on this page are snapped to the nearest listed BIOA chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are BIOA covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the BIOA covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 55.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BIOA covered call?
- The breakeven for the BIOA covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The BIOA market-implied 1-standard-deviation expected move in the same options snapshot is approximately 16.03%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on BIOA?
- Covered calls on BIOA are an income strategy run on existing BIOA stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current BIOA implied volatility affect this covered call?
- BIOA ATM IV is at 55.90% with IV rank near 8.43%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.